Associate Professor
Duke University Medical Center
C. Rory Goodwin, MD, PhD is the Director for Spinal Oncology, Surgical Director for the Duke Center for Brain and Spine Metastasis, Associate Residency Program Director, and an Associate Professor of Neurosurgery, Radiation Oncology, Orthopaedic Surgery, and Mechanical Engineering and Materials Science at the Duke University Medical Center. Dr. Goodwin attended the University of Florida where he majored in Neurobiological Sciences and Business Administration with minors in Chemistry and Economics. He obtained his M.D. and Ph.D. in Neuroscience from the Johns Hopkins University School of Medicine while also leading, founding, and participating in programs focused on future and current underrepresented minority students. He completed his Neurosurgery residency at the Johns Hopkins Hospital and has received research awards from the UNCF-Merck Science Initiative and the Burroughs Wellcome Fund, Robert Wood Johnson Foundation, and the NIH. Over the course of his training, he served as a Medical Officer for the Food and Drug Administration, Division of Orthopedic Devices, graduated from the Global Clinical Scholars Research Training Program at Harvard Medical School and also completed an in-folded Complex Spine Fellowship at The Johns Hopkins Hospital. Dr. Goodwin has over 300 peer-reviewed manuscripts as well over 300 conference abstracts and presentations. He has a clinical research interest in surgical decision-making and algorithms to predict clinical outcomes for patients diagnosed with spinal tumors, and a basic science interest in genomic and proteomic mediators of primary and metastatic spine tumor formation and progression.
Disclosure(s): ‘Stryker: Research Grant (Terminated); Carlsmed: Research Grant (Ongoing); Icotec: Consultant (Ongoing), Research Grant (Ongoing), Speaker/Honoraria (Ongoing); Medtronic: Consultant (Ongoing)
Monday, May 4, 2026
9:05 AM - 9:14 AM CT
Monday, May 4, 2026
9:15 AM - 9:24 AM CT
Two or More Level Spondylectomy for Primary Spine Tumors
Monday, May 4, 2026
10:05 AM - 10:14 AM CT